Pharmaceutical Schedule

A Practical Guide to Producing and Maintaining the PSMF

Vigilance

16

A Practical Guide to Writing Risk Management Plans (RMPs)

Vigilance

20

19

A Practical Introduction to Good Clinical Practice (GCP)

New for 2026

GxP

15

6

AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects

Artificial Intelligence (AI) in Life Sciences

11

5

AI in Pharmacovigilance

Artificial Intelligence (AI) in Life Sciences

18

APIs in Focus: Understanding ICH, GMP and Supply Chain Excellence

GxP

29-30

21-22

Achieving Publication Success in Scientific Journals

New for 2026

Medical Writing

21

Additional Risk Minimization Measures (aRMMs) and Their Effectiveness

Vigilance

16

2

Advanced Pharmacovigilance: From Performing Successful Due Diligence to Benefit-Risk Assessments – What to Consider

Vigilance

23-25

21-25

An Essential Overview of Medical Information

Regulatory Affairs

22

3

An Essential Overview of the Pharmaceutical and Biotech Industries

Regulatory Affairs

28

An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals

Medical Devices

8

19

An Introduction to Signal Detection

New for 2026

Vigilance

16

14

An Introduction to Technology Transfer for Solid Dosage Forms

New for 2026

GxP

18

An Overview of EU and UK Regulatory Affairs

Regulatory Affairs

21-22

An Overview of Ethical Standards in Clinical Research Publication

New for 2026

GxP

13

11

Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions

New for 2026

Regulatory Affairs

10

9

Behavioural Risk Management in Clinical Trials

New for 2026

Clinical Research

13

5

Best Practices for Supplier Qualification in Life Science

Medical Devices

6-7

12-13

Biosimilars

Biopharma

22-23

Biotechnology for the Non-Biotechnologist

Biopharma

10-12

30-4

Building The Business Case For Pharma 4.0

New for 2026

Medical Technology

13

6

CAPA (Corrective and Preventative Action)

Regulatory Affairs

15

4

Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products

GxP

23-24

19-20

Cleaning Validation - Best Practice in Pharmaceuticals

GxP

23-24

1-2

Clinical & Post-Marketing Safety

New for 2026

Vigilance

11-12

16-17

Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application

Regulatory Affairs

16-17

30-1

Clinical Quality Management Systems (CQMS): A Practical Guide to Inspection Readiness

Clinical Research

23-24

17-18

Clinical Research Project Management

Medical Devices

29-1

21-23

Clinical Trial Agreements: Key Legal, Regulatory and IP Considerations for the EU and UK Markets

New for 2026

Commercial Contracts

18

2

24

Clinical Trial Monitoring

Clinical Research

18-19

10-11

Clinical Trial Regulatory Requirements

Clinical Research

14-15

Clinical Trials in the MENA Region

New for 2026

Clinical Research

6

11

Cosmetovigilance

Cosmetics

18-19

8-9

Data Integrity Auditor Masterclass

GxP

22-23

14-15

Data Integrity and Document Management

Medical Devices

22

8

Dealing With Scientific Journal Reviewers: From Comments to Resubmission

New for 2026

Medical Devices

15

1

Development of Combination Products: Critical Interactions

GxP

16-17

Digital CMC

New for 2026

Medical Technology

6

2

Digital CMC: The Key To Realising Pharma 4.0

New for 2026

Regulatory Affairs

23

4

Digital Technology Transfers

New for 2026

Medical Technology

22

Drafting Commercial Contracts for the Pharmaceutical Industry

Commercial Contracts

20-21

11-12

EU Pharmaceutical Regulations and Strategy

Regulatory Affairs

5-6

EU Proposed Pharmaceutical Legislation Changes

Regulatory Affairs

1

Effective Change Management in Pharma

New for 2026

GxP

17

9

Effective Communication & Negotiation in Technology Transfers

New for 2026

GxP

18

15

Effective Deviation Management Systems in Pharma

New for 2026

GxP

20

25

Effective Regulatory Compliance for Storage and Distribution in Pharma Supply Chains

New for 2026

GxP

15

20

Effective Technical Writing & Editing

Medical Writing

15

18

Effective Technology Transfer

GxP

8-9

Ensuring Clinical Research Quality & Patient Safety

New for 2026

GxP

14

Essential Documentation Skills for Clinical Research Compliance

New for 2026

GxP

5

GCP and Clinical Research Update: What Inspectors Are Focusing on Now

Clinical Research

19

20

GMP Principles in Vaccine Manufacturing

GxP

16-17

8-9

Golden Rules of Being a Successful GMP Auditor

New for 2026

GxP

30-1

Good Distribution Practices of Pharmaceuticals and APIs

GxP

14-15

16-17

Good Writing Practice for Clinical Research: Ethics, Standards & Compliance

New for 2026

GxP

20

18

How to Audit Pharmaceutical Suppliers (Material and Service)

New for 2026

GxP

14-15

How to Deal with Difficult Situations in GMP Audits

New for 2026

GxP

28

How to Interview During GMP Audits

GxP

24

How to Manage Internal GMP Audits

New for 2026

GxP

21-22

How to Pass International Health Authority Inspections

New for 2026

GxP

16-17

7-8

How to Perform Bullet-Proof Good Distribution Practices (GDP) and Good Storage Practices (GSP) Audits

New for 2026

GxP

18-19

10-11

ICH GCP E6 (R3): What You Need to Know for Implementation and Inspection

New for 2026

Clinical Research

13

ICH Q9(R1) Quality Risk Management (QRM)

GxP

25

4

Literature Searching in Drug Safety

Vigilance

14-15

10-11

Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3

Animal Health

13-14

15-16

Mastering CTD Submissions in the MENA Region

Regulatory Affairs

19

26

Mastering Computer System Validation

GxP

17-18

10-11

Mastering Ethical and Effective Scientific Publishing: Applying Good Publication Practice (GPP)

New for 2026

Medical Writing

8

Mastering Grant Writing: Essential Skills for Crafting Winning Proposals

New for 2026

Medical Writing

22-23

8-9

Measuring Performance in Clinical Research Management

Clinical Research

6

23

Medical Editing for Peer-Reviewed Journals

New for 2026

Medical Writing

8

4

Medical Writing Excellence: Crafting Compelling Scientific Documents

New for 2026

Medical Writing

30-1

Medical Writing for Consumers

New for 2026

Medical Writing

21

1

Medical Writing with AI

New for 2026

Artificial Intelligence (AI) in Life Sciences

18

8

Microbiomics in Clinical Trials

New for 2026

Clinical Research

14

Molecular Biology for the Non-Molecular Biologist

Biopharma

20-21

8-9

Navigating EU Product Classification: Foods, Supplements & Herbal Medicines Masterclass

Updated for 2026

Regulatory Affairs

12

4

Navigating EU and FDA Regulations for Drug/Device and Device/Drug Combination Products

Updated for 2026

Medical Devices

14-15

New EU GMP Annex 1: Compliant Sterile Medicinal Products

GxP

19-21

24-26

Orphan Drug Regulatory Masterclass: EU & US Insights

Regulatory Affairs

4

6

Pharmaceutical Development of ATMPs

GxP

18-19

28-29

Pharmaceutical Packaging Essentials: From Regulatory Compliance to Market Success

GxP

22-24

Pharmaceutical Regulatory Affairs in Africa

Regulatory Affairs

6-7

3-4

Pharmaceutical Regulatory Affairs in Asia

Regulatory Affairs

24-26

20-22

Pharmaceutical Regulatory Affairs in China

Regulatory Affairs

3-4

25-26

Pharmaceutical Regulatory Affairs in Russia, Eurasian Union and the CIS

Regulatory Affairs

5-6

30-1

Pharmaceutical Regulatory Affairs in the Middle East

Regulatory Affairs

20-21

Pharmaceutical Regulatory Affairs in the Middle East and North Africa

New for 2026

Regulatory Affairs

2-4

Pharmacovigilance Aspects of Licensing Agreements

Vigilance

25

10-11

Pharmacovigilance QMS & Inspection Preparation

Vigilance

27-28

8-9

Pharmacovigilance: An Overview of Drug Safety from Safety Collection to Regulatory Inspection

Vigilance

30

5-6

Practical Requirements of the Arab Pharmacovigilance Guidelines

Vigilance

21-22

Practical Risk Management in Clinical Research and Trials

Clinical Research

24

6

Process Validation with Qualification

GxP

3-4

1-2

Protein Engineering for Pharmaceutical Biotechnology

New for 2026

Biopharma

7-8

Risk Evaluation and Mitigation Strategies (REMS) vs Risk Management Plans (RMP)

New for 2026

Vigilance

14

Selecting the Best Scientific Journal for Your Research

New for 2026

Medical Devices

13

19

Signal Detection and Regulatory Expectations

Vigilance

30-1

Signal Detection: A Comprehensive Introduction

New for 2026

Vigilance

1

Smart Packaging and Electronic Patient Information

Medical Devices

21

2-3

Stability Testing of Pharmaceuticals and Biopharmaceuticals

GxP

20-22

9-11

Successful Medical Writing – from Protocol to CTD

Medical Writing

22-23

The 2024 EU AI Act

New for 2026

Artificial Intelligence (AI) in Life Sciences

23

3

The Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries

New for 2026

Biopharma

15-16

The Common Technical Document

GxP

14-15

21-22

The FDA Drug Approval Process

Regulatory Affairs

24-25

The Principles & Applications of CRISPR

New for 2026

Biopharma

7

The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry

Regulatory Affairs

20-21

12-13

Thinking Outside of the GMP Box

GxP

16-17

US FDA - Understanding Key Factors When Working with the FDA

Biopharma

12

25

Understanding Scientific Journal Submission and Publication

New for 2026

Medical Devices

11

16

Understanding Toxicology: A Guide for Non-Toxicologists

New for 2026

Regulatory Affairs

15

Upstream and Downstream Manufacturing in the Biopharmaceutical Industry

New for 2026

GxP

11

18

Variations to Marketing Authorisations

Regulatory Affairs

2-3

11-12

Writing Inspection-Ready SOPs: Best Practice for Compliance and Control

Regulatory Affairs

26

14

26

Pharmaceutical Training Course Calendar

Our Pharmaceutical calendar for the next 12 months:

Live online Classroom		Mar	Apr	May	Jun	Jul	Sep	Oct	Nov	Dec	Jan
Live online Classroom		2026									2027
A Practical Guide to Producing and Maintaining the PSMF	Vigilance						16
A Practical Guide to Writing Risk Management Plans (RMPs)	Vigilance	20						19
A Practical Introduction to Good Clinical Practice (GCP) New for 2026	GxP		15					6
AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects	Artificial Intelligence (AI) in Life Sciences			11					5
AI in Pharmacovigilance	Artificial Intelligence (AI) in Life Sciences			18					18
APIs in Focus: Understanding ICH, GMP and Supply Chain Excellence	GxP		29-30					21-22
Achieving Publication Success in Scientific Journals New for 2026	Medical Writing						21
Additional Risk Minimization Measures (aRMMs) and Their Effectiveness	Vigilance				16					2
Advanced Pharmacovigilance: From Performing Successful Due Diligence to Benefit-Risk Assessments – What to Consider	Vigilance	23-25					21-25
An Essential Overview of Medical Information	Regulatory Affairs				22					3
An Essential Overview of the Pharmaceutical and Biotech Industries	Regulatory Affairs						28
An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals	Medical Devices			8					19
An Introduction to Signal Detection New for 2026	Vigilance		16					14
An Introduction to Technology Transfer for Solid Dosage Forms New for 2026	GxP						18
An Overview of EU and UK Regulatory Affairs	Regulatory Affairs						21-22
An Overview of Ethical Standards in Clinical Research Publication New for 2026	GxP			13						11
Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions New for 2026	Regulatory Affairs				10					9
Behavioural Risk Management in Clinical Trials New for 2026	Clinical Research		13					5
Best Practices for Supplier Qualification in Life Science	Medical Devices			6-7					12-13
Biosimilars	Biopharma						22-23
Biotechnology for the Non-Biotechnologist	Biopharma				10-12				30-4
Building The Business Case For Pharma 4.0 New for 2026	Medical Technology		13					6
CAPA (Corrective and Preventative Action)	Regulatory Affairs				15					4
Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products	GxP		23-24					19-20
Cleaning Validation - Best Practice in Pharmaceuticals	GxP				23-24					1-2
Clinical & Post-Marketing Safety New for 2026	Vigilance			11-12					16-17
Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application	Regulatory Affairs	16-17					30-1
Clinical Quality Management Systems (CQMS): A Practical Guide to Inspection Readiness	Clinical Research	23-24					17-18
Clinical Research Project Management	Medical Devices		29-1					21-23
Clinical Trial Agreements: Key Legal, Regulatory and IP Considerations for the EU and UK Markets New for 2026	Commercial Contracts	18				2			24
Clinical Trial Monitoring	Clinical Research				18-19					10-11
Clinical Trial Regulatory Requirements	Clinical Research						14-15
Clinical Trials in the MENA Region New for 2026	Clinical Research			6					11
Cosmetovigilance	Cosmetics				18-19					8-9
Data Integrity Auditor Masterclass	GxP		22-23					14-15
Data Integrity and Document Management	Medical Devices				22					8
Dealing With Scientific Journal Reviewers: From Comments to Resubmission New for 2026	Medical Devices				15					1
Development of Combination Products: Critical Interactions	GxP						16-17
Digital CMC New for 2026	Medical Technology			6					2
Digital CMC: The Key To Realising Pharma 4.0 New for 2026	Regulatory Affairs				23					4
Digital Technology Transfers New for 2026	Medical Technology						22
Drafting Commercial Contracts for the Pharmaceutical Industry	Commercial Contracts			20-21					11-12
EU Pharmaceutical Regulations and Strategy	Regulatory Affairs							5-6
EU Proposed Pharmaceutical Legislation Changes	Regulatory Affairs					1
Effective Change Management in Pharma New for 2026	GxP		17					9
Effective Communication & Negotiation in Technology Transfers New for 2026	GxP			18				15
Effective Deviation Management Systems in Pharma New for 2026	GxP	20					25
Effective Regulatory Compliance for Storage and Distribution in Pharma Supply Chains New for 2026	GxP			15					20
Effective Technical Writing & Editing	Medical Writing			15					18
Effective Technology Transfer	GxP				8-9					8-9
Ensuring Clinical Research Quality & Patient Safety New for 2026	GxP						14
Essential Documentation Skills for Clinical Research Compliance New for 2026	GxP							5
GCP and Clinical Research Update: What Inspectors Are Focusing on Now	Clinical Research			19					20
GMP Principles in Vaccine Manufacturing	GxP				16-17					8-9
Golden Rules of Being a Successful GMP Auditor New for 2026	GxP						30-1
Good Distribution Practices of Pharmaceuticals and APIs	GxP			14-15					16-17
Good Writing Practice for Clinical Research: Ethics, Standards & Compliance New for 2026	GxP		20						18
How to Audit Pharmaceutical Suppliers (Material and Service) New for 2026	GxP						14-15
How to Deal with Difficult Situations in GMP Audits New for 2026	GxP						28
How to Interview During GMP Audits	GxP						24
How to Manage Internal GMP Audits New for 2026	GxP						21-22
How to Pass International Health Authority Inspections New for 2026	GxP		16-17					7-8
How to Perform Bullet-Proof Good Distribution Practices (GDP) and Good Storage Practices (GSP) Audits New for 2026	GxP				18-19					10-11
ICH GCP E6 (R3): What You Need to Know for Implementation and Inspection New for 2026	Clinical Research					13
ICH Q9(R1) Quality Risk Management (QRM)	GxP				25					4
Literature Searching in Drug Safety	Vigilance			14-15					10-11
Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3	Animal Health		13-14					15-16
Mastering CTD Submissions in the MENA Region	Regulatory Affairs			19					26
Mastering Computer System Validation	GxP				17-18					10-11
Mastering Ethical and Effective Scientific Publishing: Applying Good Publication Practice (GPP) New for 2026	Medical Writing					8
Mastering Grant Writing: Essential Skills for Crafting Winning Proposals New for 2026	Medical Writing				22-23					8-9
Measuring Performance in Clinical Research Management	Clinical Research			6					23
Medical Editing for Peer-Reviewed Journals New for 2026	Medical Writing			8					4
Medical Writing Excellence: Crafting Compelling Scientific Documents New for 2026	Medical Writing						30-1
Medical Writing for Consumers New for 2026	Medical Writing		21					1
Medical Writing with AI New for 2026	Artificial Intelligence (AI) in Life Sciences				18					8
Microbiomics in Clinical Trials New for 2026	Clinical Research						14
Molecular Biology for the Non-Molecular Biologist	Biopharma		20-21					8-9
Navigating EU Product Classification: Foods, Supplements & Herbal Medicines Masterclass Updated for 2026	Regulatory Affairs				12					4
Navigating EU and FDA Regulations for Drug/Device and Device/Drug Combination Products Updated for 2026	Medical Devices						14-15
New EU GMP Annex 1: Compliant Sterile Medicinal Products	GxP			19-21					24-26
Orphan Drug Regulatory Masterclass: EU & US Insights	Regulatory Affairs	4						6
Pharmaceutical Development of ATMPs	GxP	18-19					28-29
Pharmaceutical Packaging Essentials: From Regulatory Compliance to Market Success	GxP						22-24
Pharmaceutical Regulatory Affairs in Africa	Regulatory Affairs			6-7					3-4
Pharmaceutical Regulatory Affairs in Asia	Regulatory Affairs	24-26						20-22
Pharmaceutical Regulatory Affairs in China	Regulatory Affairs				3-4				25-26
Pharmaceutical Regulatory Affairs in Russia, Eurasian Union and the CIS	Regulatory Affairs	5-6					30-1
Pharmaceutical Regulatory Affairs in the Middle East	Regulatory Affairs							20-21
Pharmaceutical Regulatory Affairs in the Middle East and North Africa New for 2026	Regulatory Affairs				2-4
Pharmacovigilance Aspects of Licensing Agreements	Vigilance				25					10-11
Pharmacovigilance QMS & Inspection Preparation	Vigilance		27-28					8-9
Pharmacovigilance: An Overview of Drug Safety from Safety Collection to Regulatory Inspection	Vigilance		30					5-6
Practical Requirements of the Arab Pharmacovigilance Guidelines	Vigilance		21-22					21-22
Practical Risk Management in Clinical Research and Trials	Clinical Research		24					6
Process Validation with Qualification	GxP				3-4					1-2
Protein Engineering for Pharmaceutical Biotechnology New for 2026	Biopharma					7-8
Risk Evaluation and Mitigation Strategies (REMS) vs Risk Management Plans (RMP) New for 2026	Vigilance						14
Selecting the Best Scientific Journal for Your Research New for 2026	Medical Devices		13					19
Signal Detection and Regulatory Expectations	Vigilance						30-1
Signal Detection: A Comprehensive Introduction New for 2026	Vigilance					1
Smart Packaging and Electronic Patient Information	Medical Devices			21					2-3
Stability Testing of Pharmaceuticals and Biopharmaceuticals	GxP			20-22					9-11
Successful Medical Writing – from Protocol to CTD	Medical Writing						22-23
The 2024 EU AI Act New for 2026	Artificial Intelligence (AI) in Life Sciences				23					3
The Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries New for 2026	Biopharma						15-16
The Common Technical Document	GxP			14-15				21-22
The FDA Drug Approval Process	Regulatory Affairs						24-25
The Principles & Applications of CRISPR New for 2026	Biopharma					7
The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry	Regulatory Affairs		20-21					12-13
Thinking Outside of the GMP Box	GxP						16-17
US FDA - Understanding Key Factors When Working with the FDA	Biopharma			12					25
Understanding Scientific Journal Submission and Publication New for 2026	Medical Devices			11					16
Understanding Toxicology: A Guide for Non-Toxicologists New for 2026	Regulatory Affairs					15
Upstream and Downstream Manufacturing in the Biopharmaceutical Industry New for 2026	GxP				11				18
Variations to Marketing Authorisations	Regulatory Affairs				2-3				11-12
Writing Inspection-Ready SOPs: Best Practice for Compliance and Control	Regulatory Affairs	26				14			26